// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Evaluating novel peptide therapeutics targeting pathogenic macrophages in systemic sclerosis

James Stanway - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Serum tryptophan and kynurenine levels are altered in systemic sclerosis patients and show distinct clinical and autoantibody associations suggesting potential role in pathogenesis

Corrado Campochiaro - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

tryptophan

Imaging calcinosis in patients with systemic sclerosis by radiography, computerised tomography and magnetic resonance imaging

Michael Hughes - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Raynaud syndrome

N/A

NOX1/NOX4 inhibition blocks the profibrotic activity of scleroderma fibroblasts

Hannah Murphy-Marshman - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

Setanaxib

Serious erythroderma occurring in an anti-SAE-1 positive dermatomyositis (DM) patient

Leanne Gray - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Juvenile dermatomyositis

Prednisolone

Prevalence of coeliac antibodies in patients with primary Sjögrens syndrome

Judith Jade - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Self reported alopecia in an ethnically diverse lupus cohort

Arabella Waller - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anxiety

N/A

Cross sectional validation of BILAG2004-Pregnancy Index

Chee-Seng Yee - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does skeletal muscle mitochondrial dysfunction explain SLE related physical fatigue?

Neil Basu - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Proton pump inhibitor induced subacute cutaneous lupus erythematosus: clinical characteristics and outcomes

Yih Jia Poh - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Cutaneous lupus erythematosus

N/A

Motor and cognitive fatigue in SLE is associated with mood and health-related quality of life (HRQoL) in patients with SLE: results from the Patient Reported Outcomes in Lupus (PRO-Lupus) study

Amy Bland - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

N/A

Predictors of hypogammaglobulinaemia in rituximab treated systemic lupus erythematosus and vasculitis patients

Virginia Casigliani - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Rituximab

Disease trends and phenotypes among different age groups: a study in lupus

Giuseppe A Ramirez - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Moving with the times: social media use amongst lupus patients

Lily M Wheeler - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

An alternative way of cracking vasculitis: case series of three patients with cocaine-induced vasculitis

Kavina Shah - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biologics in the treatment of relapsing polychondritis

Yih Jia Poh - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Relapsing polychondritis

N/A

Rituximab treatment for refractory immunoglobulin G4 related disease

Alina Casian - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immunoglobulin G4 related disease

Rituximab

All patients with possible giant cell arteritis should be seen by a rheumatologist before temporal artery biopsy

Vanessa Quick - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Prednisolone

The role of musculoskeletal ultrasound as a diagnostic and management tool for assessment of inflammatory arthritis associated with systemic lupus erythematosus and Sjögrens syndrome patients

Stephen J Morgan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Long-term (four year) 28-joint count disease activity score (C-reactive protein) remission and improvements in skin disease with apremilast: phase III results from PALACE3

Christopher Edwards - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriasis

Apremilast

Copyright © 2026. QuantiNova All rights reserved